These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 20846160)
1. Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. Mannering SI; Wong FS; Durinovic-Belló I; Brooks-Worrell B; Tree TI; Cilio CM; Schloot NC; Mallone R; Clin Exp Immunol; 2010 Nov; 162(2):197-209. PubMed ID: 20846160 [TBL] [Abstract][Full Text] [Related]
2. Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime". Kent SC; Mannering SI; Michels AW; Babon JAB Curr Diab Rep; 2017 Sep; 17(10):95. PubMed ID: 28864875 [TBL] [Abstract][Full Text] [Related]
3. T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus. Kallan AA; de Vries RR; Roep BO APMIS; 1996 Jan; 104(1):3-11. PubMed ID: 8645454 [TBL] [Abstract][Full Text] [Related]
4. The potential of multimer technologies in type 1 diabetes prediction strategies. Fierabracci A Diabetes Metab Res Rev; 2011 Mar; 27(3):216-29. PubMed ID: 21309048 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic islet autoimmunity. Boitard C Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678 [TBL] [Abstract][Full Text] [Related]
6. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614 [TBL] [Abstract][Full Text] [Related]
7. Prevention of type 1 diabetes. Rabinovitch A; Skyler JS Med Clin North Am; 1998 Jul; 82(4):739-55. PubMed ID: 9706119 [TBL] [Abstract][Full Text] [Related]
8. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802 [TBL] [Abstract][Full Text] [Related]
10. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes. Peakman M; Tree TI; Endl J; van Endert P; Atkinson MA; Roep BO; Diabetes; 2001 Aug; 50(8):1749-54. PubMed ID: 11473034 [TBL] [Abstract][Full Text] [Related]
11. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. Inoue Y; Kaifu T; Sugahara-Tobinai A; Nakamura A; Miyazaki J; Takai T J Immunol; 2007 Jul; 179(2):764-74. PubMed ID: 17617565 [TBL] [Abstract][Full Text] [Related]
12. T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Roep BO Diabetes; 1996 Sep; 45(9):1147-56. PubMed ID: 8772714 [TBL] [Abstract][Full Text] [Related]
13. Human islets and dendritic cells generate post-translationally modified islet autoantigens. McLaughlin RJ; de Haan A; Zaldumbide A; de Koning EJ; de Ru AH; van Veelen PA; van Lummel M; Roep BO Clin Exp Immunol; 2016 Aug; 185(2):133-40. PubMed ID: 26861694 [TBL] [Abstract][Full Text] [Related]
14. The use of idd congenic mice to identify checkpoints of peripheral tolerance to islet antigen. Hamilton-Williams EE; Martinez X; Lyman M; Hunter K; Wicker LS; Sherman LA Ann N Y Acad Sci; 2007 Apr; 1103():118-27. PubMed ID: 17376833 [TBL] [Abstract][Full Text] [Related]
15. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes. So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329 [TBL] [Abstract][Full Text] [Related]
16. Islet antigen-specific T cell clones in autoimmune diabetes: from mice to men. Schloot NC; Roep BO Diabetes Metab Rev; 1997 Sep; 13(3):127-38. PubMed ID: 9307886 [No Abstract] [Full Text] [Related]
17. Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells. Roberts SA; Barbour G; Matarrese MR; Mason DL; Leiter EH; Haskins K; Hanson MS J Autoimmun; 2003 Sep; 21(2):139-47. PubMed ID: 12935783 [TBL] [Abstract][Full Text] [Related]
18. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395 [TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of autoimmune diabetes by antigen based immune modulation: are we there yet? Bot A; von Herrath M Minerva Med; 2004 Apr; 95(2):105-14. PubMed ID: 15272245 [TBL] [Abstract][Full Text] [Related]
20. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Chosich N; Harrison LC Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]